Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response
US8551500B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 8, 2008 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Jul 10, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns an immunogenic composition comprising: i) an antigenic polypeptide consisting of a fragment of the protein histone H2B of Leishmania, said fragment including the N-terminal region of said protein histone H2B, and ii) an adjuvant stimulating the immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.